Skip to main content
. Author manuscript; available in PMC: 2015 Apr 10.
Published in final edited form as: J Diabetes Complications. 2015 Jan 13;29(3):433–437. doi: 10.1016/j.jdiacomp.2015.01.004

Table 2.

Results of the various variables in each group.

Variable Week Paricalcitol (N = 23) P value Placebo (N = 23) P value
Hemoglobin A1c (%) 0 7.4, 5.2–9.4 0.28 7.3, 5.8–10.6 0.36
12 7.2, 5.9–11.1 7.5, 5.7–10.2
F M dilation (%) 0 3.4, −10.1–17.9 0.73 2.4, −30.1–21.3 0.85
12 3.3, −7.5–14.4 3.6, −3.4–17.1
N G dilation (%) 0 7.8, 0.9–30.3 0.18 9.7, −1.7–33.3 0.36
12 4.2, 0.3–24.3 9.8, −2.5–30.0
Microalbumin/Cr (μg/mg) 0 41.0, 1.9–1806 0.35 83.3, 1.3–7713.9 0.60
12 69.1, 1.7–8405 56.1, 1.7–8332.0
Urinary Isoprostane/Cr (ng/ml) 0 2.5, 0.7–6.3 0.17 1.8, 0.3–5.0 0.70
12 2.0, 0.8–5.2 2.3, 0.4–5.5
FFA (mM) 0 0.6, 0.1–1.5 0.03 0.4, 0.1–0.9 0.73
12 0.4, 0.1–1.4 0.4, 0.1–1.0
Insulin (mU/ml) 0 9.9,1.6–60.2 0.56 6.1, 0.5–38.5 0.28
12 8.8, 0.5–53.9 5.4, 0.3–21.9
MCP–1 (pg/m)l 0 246.8, 75.6–674.9 0.46 275.9, 120.4–781.4 0.93
12 268.0, 83.1–585.0 300.9, 120.4–637.6
TNF-α (pg/ml) 0 2.5, 1.5–3.6 0.58 2.5, 1.6–4.5 0.13
12 2.6, 1.6–3.9 2.6, 1.1–4.2
IL-6 (pg/ml) 0 2.8, 0.8–25.4 0.11 2.5, 1.1–26.0 0.27
12 2.5, 0.4–24.0 2.7, 1.2–25.0
ICAM-1 (ng/ml) 0 242.8, 72.8–521.2 0.34 179.8, 64.9–612.8 0.34
12 225.4, 78.2–387.8 182.0, 69.2–366.9
CRP (mg/ml) 0 7.4, 0.2–13.2 0.32 4.3, 0.2–13.1 0.02
12 5.8, 0.3–12.9 6.9, 0.8–13.0

Data are median with range.